STOCK TITAN

Trulieve Announces Planned Termination of Executive Automatic Securities Disposition Plan

(Neutral)
Tags

Trulieve (NYSE: TRLV) announced that CEO and Chair Kim Rivers plans to terminate her automatic securities disposition plan (ASDP) in the next open trading window on August 11, 2026.

The Rule 10b5‑1 plan covered 2.5 million shares; 1,699,007 have already been sold in the first tranche.

Loading...
Loading translation...

Positive

  • Planned termination of ASDP before any second-tranche share sales
  • Potentially avoids further sales of up to 800,993 shares under the ASDP

Negative

  • CEO has already sold 1,699,007 subordinate voting shares under the ASDP's first tranche

News Market Reaction – TRLV

+2.78%
2 alerts
+2.78% Session close to close
$1.75B Market Cap
0.4x Rel. Volume

In the Jun 29 session, TRLV gained 2.78%, reflecting a moderate positive market reaction. Our momentum scanner triggered 2 alerts that day, indicating moderate trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement highlights the CEO’s plan to terminate a Rule 10b5‑1 ASDP after selling 1,699,007 ...
Analysis

This announcement highlights the CEO’s plan to terminate a Rule 10b5‑1 ASDP after selling 1,699,007 of 2,500,000 planned shares. Recent Form 4 data show net insider selling; investors may monitor future trading windows for any change in behavior.

Key Figures

ASDP planned shares: 2,500,000 shares First tranche completed: 1,699,007 subordinate voting shares Number of tranches: 2 tranches +4 more
7 metrics
ASDP planned shares 2,500,000 shares Total shares authorized for sale under Ms. Rivers' ASDP
First tranche completed 1,699,007 subordinate voting shares Shares sold under first tranche as of June 26, 2026
Number of tranches 2 tranches Structure of Ms. Rivers' automatic securities disposition plan
Plan adoption date March 16, 2026 Date ASDP was adopted under Rule 10b5‑1 conditions
First tranche start June 17, 2026 Date sales under the first tranche began
Second tranche start (planned) September 15, 2026 Scheduled start date for second tranche before termination notice
Planned termination date August 11, 2026 Date Ms. Rivers intends to terminate the ASDP in open window

Key Terms

automatic securities disposition plan, rule 10b5‑1, subordinate voting shares
3 terms
automatic securities disposition plan financial
"administering her automatic securities disposition plan ("ASDP") of her intention"
An automatic securities disposition plan is a pre-set program that sells or transfers a person’s or entity’s shares on a scheduled or trigger-based routine without further decisions at the time of each sale. It matters to investors because such plans increase the predictability of when new shares may enter the market—like an automatic bill payment for stock—reducing questions about insider timing and helping assess potential short-term pressure on a company’s share price.
rule 10b5‑1 regulatory
"open trading window consistent with the conditions of Rule 10b5‑1 under the"
A Securities and Exchange Commission rule that lets company insiders establish a written, prearranged plan to buy or sell company stock so those trades won’t be treated as illegal insider trading later, provided the plan was set up when they did not possess important secret information and they cannot later change or influence the trades. It matters to investors because such plans make insider activity more predictable and reduce suspicion of opportunistic trades—like setting up an automatic payment schedule that runs on its own even if circumstances change.
subordinate voting shares financial
"tranche of share sales totaling 1,699,007 subordinate voting shares has been"
Subordinate voting shares are a type of company stock that typically carry fewer voting rights than regular shares, meaning holders have less influence over company decisions. They are often used to raise capital while allowing founders or main shareholders to retain control. For investors, understanding the difference helps assess their level of influence in company decisions and the potential risks or benefits of holding different types of shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

TALLAHASSEE, Fla., June 26, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (NYSE: TRLV) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced that Ms. Kim Rivers, the Company's Chairman and Chief Executive Officer, has notified the broker dealer administering her automatic securities disposition plan ("ASDP") of her intention to terminate the plan during the Company's next open trading window on August 11, 2026.

Trulieve logo

The ASDP, which was adopted on March 16, 2026, was initiated during an open trading window consistent with the conditions of Rule 10b5‑1 under the Securities Exchange Act of 1934. The plan provided for the orderly sale of 2.5 million shares to be sold in two tranches. Sales under the first tranche began on June 17, 2026, with the second tranche sales set to start on September 15, 2026. As of June 26, 2026, the first tranche of share sales totaling 1,699,007 subordinate voting shares has been completed. Ms. Rivers has notified the broker dealer administering the plan of her intention to terminate the plan on August 11, 2026, during the next open trading window, prior to any share sales under the second tranche.

Forward-Looking Statements
This news release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to known and unknown risks, uncertainties, and other factors which may cause actual events, results, performance, or achievements of the Company to be materially different from those contained in the forward-looking statements. Risks and uncertainties include, without limitation, the risks and factors discussed under the heading "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2025 and in our periodic reports subsequently filed with the United States Securities and Exchange Commission and in the Company's filings on SEDAR+ at www.sedarplus.ca. There can be no assurance that any forward-looking statements herein will prove to be accurate, and accordingly readers are advised to rely on their own evaluation of such risks and uncertainties and should not place undue reliance upon such forward-looking information and statements. Any forward-looking information and statements herein are made as of the date hereof and, except as required by applicable laws, the Company assumes no obligation and disclaims any intention to update or revise any forward-looking information and statements herein or to update the reasons that actual events or results could or do differ from those projected in any forward looking information and statements herein, whether as a result of new information, future events or results, or otherwise.

About Trulieve
Trulieve is an industry leading, vertically integrated cannabis company and multi-state operator in the U.S., with established medical marijuana operations in Florida, Georgia, Pennsylvania, and West Virginia. Driven by a core mission to expand access to cannabis, Trulieve serves customers with innovative, high-quality branded products and exceptional experiences. With scaled operations in attractive markets and targeted expansion through its hub strategy, Trulieve is poised for accelerated growth. Trulieve is listed on the NYSE under the symbol TRLV. For more information, please visit Trulieve.com.

Facebook: @Trulieve   
Instagram: @Trulieve
X: @Trulieve

Investor and Media Contact
Christine Hersey, Chief Corporate Affairs & Strategy Officer
+1 (424) 202-0210
Christine.Hersey@Trulieve.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/trulieve-announces-planned-termination-of-executive-automatic-securities-disposition-plan-302812302.html

SOURCE Trulieve Cannabis Corp.

FAQ

What did Trulieve (NYSE: TRLV) announce about Kim Rivers' ASDP on June 26, 2026?

Trulieve announced that CEO Kim Rivers intends to terminate her automatic securities disposition plan on August 11, 2026. According to Trulieve, the termination will occur during the next open trading window, before any sales from the plan’s second tranche begin.

How many Trulieve (TRLV) shares were included in Kim Rivers' automatic securities disposition plan?

Kim Rivers’ ASDP provided for the orderly sale of 2.5 million Trulieve shares in two tranches. According to Trulieve, the first tranche has already executed 1,699,007 subordinate voting share sales, with the second tranche originally scheduled to start on September 15, 2026.

How many Trulieve (TRLV) shares has Kim Rivers sold under the ASDP so far?

Kim Rivers has sold 1,699,007 subordinate voting shares under the ASDP’s first tranche. According to Trulieve, these sales began on June 17, 2026 and were completed by June 26, 2026 as part of the prearranged 10b5‑1 trading plan.

When will Kim Rivers terminate her Trulieve (TRLV) automatic securities disposition plan?

Kim Rivers intends to terminate her ASDP on August 11, 2026. According to Trulieve, this termination will occur during the company’s next open trading window and before any share sales from the second tranche, originally set to start on September 15, 2026.

Was Kim Rivers' Trulieve (TRLV) ASDP adopted under Rule 10b5‑1 conditions?

Yes, the ASDP was adopted consistent with Rule 10b5‑1 conditions. According to Trulieve, Kim Rivers put the plan in place on March 16, 2026, during an open trading window, to facilitate an orderly, prearranged sale of 2.5 million company shares in two tranches.

Will there be second-tranche insider share sales under Trulieve (TRLV) CEO Kim Rivers' ASDP?

Second-tranche sales are not expected if the plan is terminated as intended. According to Trulieve, Kim Rivers plans to end the ASDP on August 11, 2026, before any second-tranche sales that were scheduled to begin on September 15, 2026.